The global hemodialysis and peritoneal dialysis market, valued at US$87.2 billion in 2023, increased to US$92.0 billion in 2024 and is projected to grow at a CAGR of 6.5% from 2024 to 2029, reaching approximately US$126.2 billion by 2029. The market’s growth is largely driven by the rising prevalence of chronic kidney disease (CKD), increasing incidence of diabetes and hypertension, and a rapidly aging global population that is more susceptible to kidney disorders. Technological advancements in dialysis equipment, increasing patient preference for home dialysis therapies, and favorable reimbursement policies are also contributing to the expansion of the market. Despite these positive trends, the market faces certain restraints such as complications associated with dialysis procedures and product recalls. Nevertheless, emerging economies such as China, India, and Brazil present promising growth opportunities due to rising healthcare investments and expanding dialysis infrastructure.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1279
Rising Prevalence of Chronic Kidney Disease Driving Dialysis Demand
One of the most significant drivers fueling the growth of the hemodialysis and peritoneal dialysis market is the increasing global prevalence of chronic kidney disease (CKD). CKD affects more than 10% of the global population, making it a major public health concern. As CKD progresses to end-stage renal disease (ESRD), patients require renal replacement therapies such as dialysis or kidney transplantation to survive. However, due to the limited availability of donor organs and the rising number of ESRD cases, dialysis remains the most widely adopted treatment option.
The growing burden of lifestyle-related diseases such as diabetes and hypertension has significantly increased the risk of kidney failure worldwide. These conditions are among the primary causes of CKD and are becoming more prevalent due to sedentary lifestyles, unhealthy diets, and aging populations. Individuals aged 65 years and older are particularly vulnerable to kidney disorders, which further contributes to the rising demand for dialysis services. According to the Centers for Disease Control and Prevention (CDC), approximately 35.5 million people in the United States were diagnosed with CKD in 2023, highlighting the substantial patient population requiring renal care.
Advancements in dialysis technologies are also improving patient outcomes and increasing adoption. Modern dialysis systems offer improved safety, enhanced monitoring capabilities, and better patient comfort. Additionally, innovations in dialysis membranes, machines, and digital monitoring tools are enabling more efficient treatment and facilitating the expansion of home-based dialysis therapies. These technological improvements, combined with the growing prevalence of kidney diseases, are expected to continue driving the demand for hemodialysis and peritoneal dialysis products and services worldwide.
Growing Preference for Home Dialysis and Expansion of Emerging Markets
The increasing shift toward home-based dialysis treatments is transforming the dialysis landscape and creating new opportunities for market growth. Patients are increasingly opting for home dialysis modalities, including home hemodialysis and peritoneal dialysis, due to their convenience, flexibility, and improved quality of life compared with traditional in-center dialysis treatments. Home dialysis allows patients to perform treatment in a comfortable environment, reduces frequent hospital visits, and often leads to better clinical outcomes when properly managed.
Technological advancements have made home dialysis more accessible and safer for patients. Portable dialysis machines, remote patient monitoring systems, and simplified dialysis procedures are enabling patients and caregivers to manage treatments more effectively outside hospital settings. In addition, home dialysis can significantly reduce healthcare costs compared with in-center dialysis, making it an attractive option for healthcare providers and governments seeking cost-efficient treatment solutions.
Emerging markets such as China, India, and Brazil are expected to offer significant growth opportunities for dialysis market players. These countries are experiencing rising incidences of diabetes and chronic kidney diseases, creating a substantial demand for dialysis services. At the same time, economic growth in these regions is leading to increased healthcare spending and improved access to advanced medical treatments. For instance, according to a 2023 article published in BMC Nephrology, the prevalence of ESRD in China is expected to reach 1,505 patients per million population by 2025.
Governments in emerging economies are also taking initiatives to expand dialysis access. In India, the Pradhan Mantri National Dialysis Programme (PMNDP) provides free dialysis services to below-poverty-line beneficiaries at district hospitals. As of December 31, 2022, nearly 1.7 million beneficiaries had received hemodialysis and peritoneal dialysis services under the program. Such initiatives are expected to significantly boost the adoption of dialysis treatments and drive market growth in developing regions.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1279
Market Challenges, Regional Trends, and Competitive Landscape
Despite strong growth prospects, the hemodialysis and peritoneal dialysis market faces several challenges that may hinder its expansion. One of the major concerns is the risk of complications associated with dialysis procedures. Patients undergoing dialysis are vulnerable to various complications, including bloodstream infections, vascular access infections, and other treatment-related issues. In hemodialysis, patients require vascular access through catheters, grafts, or fistulae, which can increase the risk of infections and hospitalization. Catheters, in particular, are associated with a higher risk of sepsis, morbidity, and mortality compared with grafts and fistulae.
Product recalls also pose a significant challenge for manufacturers operating in the dialysis market. Several recalls have occurred in recent years due to safety concerns and regulatory non-compliance. For instance, in 2023, Baxter Healthcare Corporation recalled nearly 280,000 bags of Dianeal peritoneal dialysis solution due to sterility issues linked to potential leaks. In the same year, Fresenius Medical Care recalled several hemodialysis machines because of possible exposure to toxic compounds leaking from silicone tubing components. Such recalls create financial burdens for manufacturers, disrupt supply chains, and affect market confidence.
From a regional perspective, North America is expected to maintain the largest share of the global hemodialysis and peritoneal dialysis market. The region benefits from a well-established healthcare infrastructure, strong reimbursement frameworks, increasing adoption of home dialysis therapies, and a large patient population suffering from ESRD. The North American market alone is projected to reach approximately USD 57.4 billion by 2029, growing at a CAGR of 6.2% during the forecast period.
Meanwhile, the Asia Pacific region is expected to be the fastest-growing market due to rising healthcare investments, expanding dialysis clinic networks, and increasing awareness about kidney disease treatment options. Countries such as China and India are emerging as key growth hotspots due to their large patient populations and supportive government healthcare initiatives.
Key companies operating in the global hemodialysis and peritoneal dialysis market include Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International Inc. (US), Nikkiso Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), DaVita Inc. (US), Nipro Corporation (Japan), Diaverum (Germany), Medtronic plc (Ireland), Rockwell Medical Inc. (US), Becton Dickinson and Company (US), and Dialife SA (Switzerland). These companies are focusing on strategic collaborations, acquisitions, and technological innovations to strengthen their market presence and expand their dialysis product and service portfolios.
Related Reports:
Periodontal Disease Treatment Market
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/dialysis-market-1279.html